I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Survivin-targeted nanomedicine for increased potency of abi..:
Baker, Abu
;
Syed, Asad
;
Mohany, Mohamed
...
European Journal of Pharmaceutics and Biopharmaceutics. 192 (2023) - p. 88-111 , 2023
Link:
https://doi.org/10.1016/j.ejpb.2023.10.005
RT Journal T1
Survivin-targeted nanomedicine for increased potency of abiraterone and enzalutamide against prostate cancer
UL https://suche.suub.uni-bremen.de/peid=cr-10.1016_j.ejpb.2023.10.005&Exemplar=1&LAN=DE A1 Baker, Abu A1 Syed, Asad A1 Mohany, Mohamed A1 Elgorban, Abdallah M. A1 Sajid Khan, Mohd A1 Al-Rejaie, Salim S. PB Elsevier BV YR 2023 SN 0939-6411 JF European Journal of Pharmaceutics and Biopharmaceutics VO 192 SP 88 OP 111 LK http://dx.doi.org/https://doi.org/10.1016/j.ejpb.2023.10.005 DO https://doi.org/10.1016/j.ejpb.2023.10.005 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)